Physician profile
Robert Sperling
NPI 1558351387
$4,427.43
in general payments reported to CMS, 2019-2025
24 companies · $408 in 2025
The $408 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $918 · 2020: $436 · 2021: $664 · 2022: $509 · 2023: $532 · 2024: $959 · 2025: $408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,886 · Education: $13.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,885.87 |
| Education | $13.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,170.28 | 2021-2025 | Symplicity G3, Telescope, Ffrangio |
| Boston Scientific Corporation | $813.11 | 2019-2025 | Avvigo Guidance System, Watchman Flx, Rotapro |
| Abiomed | $650.27 | 2019-2025 | Impella |
| Amgen INC. | $262.26 | 2019-2022 | |
| Heartflow, INC. | $223.12 | 2019-2025 | |
| Edwards Lifesciences Corporation | $206.54 | 2023-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Cardiovascular Systems INC. | $153.11 | 2019-2023 | |
| Philips North America LLC | $149.96 | 2020-2024 | (P84) Igt Devices Systems |
| Medtronic Vascular, INC. | $143.51 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $142.23 | 2019-2022 | |
| Esperion Therapeutics, INC. | $111.80 | 2020-2023 | Nexletol |
| Abbott Laboratories | $48.06 | 2024-2025 | Amplatzer Amulet, Pressurewire |
| Sanofi-Aventis U.S. LLC | $43.10 | 2019 | |
| Asahi Intecc USA, INC. | $41.05 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $36.51 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $36.47 | 2019-2021 | |
| Reflow Medical INC | $33.90 | 2024 | |
| Lilly USA, LLC | $31.26 | 2024 | Omvoh |
| E.R. Squibb & Sons, L.L.C. | $30.86 | 2020-2021 | |
| Lantheus Medical Imaging, INC. | $26.49 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $23.20 | 2019 | |
| Irhythm Technologies, INC. | $19.03 | 2019 | |
| B. Braun Interventional Systems INC. | $17.42 | 2025 | Cp Stent |
| Astrazeneca Pharmaceuticals LP | $13.89 | 2023 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Sperling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.